<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>The Samikhsya Odia</provider_name><provider_url>https://thesamikhsya.com/odia</provider_url><author_name>Samikhsya Bureau</author_name><author_url>https://thesamikhsya.com/odia/author/smn123/</author_url><title>Lupin receives tentative USFDA approval for Dimethyl Fumarate Delayed Release Capsules | The Samikhsya Odia</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="EQ1VY7TIUH"&gt;&lt;a href="https://thesamikhsya.com/odia/breaking-news/2298/"&gt;Lupin receives tentative USFDA approval for Dimethyl Fumarate Delayed Release Capsules&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://thesamikhsya.com/odia/breaking-news/2298/embed/#?secret=EQ1VY7TIUH" width="600" height="338" title="&#x201C;Lupin receives tentative USFDA approval for Dimethyl Fumarate Delayed Release Capsules&#x201D; &#x2014; The Samikhsya Odia" data-secret="EQ1VY7TIUH" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script type="text/javascript"&gt;
/* &lt;![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://thesamikhsya.com/odia/wp-includes/js/wp-embed.min.js
/* ]]&gt; */
&lt;/script&gt;
</html><description>(UNI) Pharma Major Lupin said that it has received tentative approval for its Dimethyl Fumarate Delayed Release Capsules, 120 mg and 240 mg from the United States Food and Drug Administration (FDA) to market a generic version of Biogen, Inc&#x2019;s Tecfidera Capsules, 120 mg and 240 mg. Lupin&#x2019;s Dimethyl Fumarate Delayed Release Capsules, 120 mg</description><thumbnail_url>https://thesamikhsya.com/odia/wp-content/uploads/2020/01/SAMIKSHYA-ODIA.png</thumbnail_url><thumbnail_width>1466</thumbnail_width><thumbnail_height>444</thumbnail_height></oembed>
